| Item | Cat. No. | Application | Isotype |
| Anti-ERBB2/CD340/HER2 mAbs [Disitamab Biosimilar] (MABL-4595) | MABL-4595 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-MS4A1/CD20 mAbs [Divozilimab Biosimilar] (MABL-4596) | MABL-4596 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-Rabies Virus Strain ERA Glycoprotein Ectodomain Epitope G-III mAbs [Docaravimab Biosimilar] (MA | MABL-4597 | ELISA, FACS, Functional assay, in vivo binding | G2b, Kappa |
| Anti-MSTN/GDF8/GDF-8 mAbs [Domagrozumab Biosimilar] (MABL-4598) | MABL-4598 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-TIGIT/WUCAM/VSTM3 mAbs [Domvanalimab Biosimilar] (MABL-4599) | MABL-4599 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-CD40LG/CD154 mAbs [Dapirolizumab Biosimilar] (MABL-4569) | MABL-4569 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-ADPRC1/CD38 mAbs [Daratumumab Biosimilar] (MABL-4570) | MABL-4570 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-Ganglioside GD2 mAbs [Daretabart Biosimilar] (MABL-4571) | MABL-4571 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-TIGIT/WUCAM/VSTM3 mAbs [Dargistotug Biosimilar] (MABL-4572) | MABL-4572 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-TACSTD2/TROP2/EGP1 mAbs [Datopotamab Biosimilar] (MABL-4573) | MABL-4573 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-MET/HGFR;MET/HGFR mAbs [Davutamig Biosimilar] (MABL-4574) | MABL-4574 | ELISA, FACS, Functional assay, in vivo binding | G4;G4, Kappa;Kappa |
| Anti-LILRA4/CD85g mAbs [Daxdilimab Biosimilar] (MABL-4575) | MABL-4575 | ELISA, FACS, Functional assay, in vivo binding | G1, Lambda |
| Anti-IFNB1 mAbs [Dazukibart Biosimilar] (MABL-4576) | MABL-4576 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-IL13 mAbs [Dectrekumab Biosimilar] (MABL-4577) | MABL-4577 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-TFRC/CD71 mAbs [Delpacibart Biosimilar] (MABL-4578) | MABL-4578 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-DLL4 mAbs [Demcizumab Biosimilar] (MABL-4579) | MABL-4579 | ELISA, FACS, Functional assay, in vivo binding | G2, Kappa |
| Anti-EGFR/ERBB1/HER1 mAbs [Demupitamab Biosimilar] (MABL-4580) | MABL-4580 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-F9;F10 mAbs [Denecimig Biosimilar] (MABL-4581) | MABL-4581 | ELISA, FACS, Functional assay, in vivo binding | G4;G4, Kappa;Kappa |
| Anti-CCR8/CKR-L1/CDw198 mAbs [Denikitug Biosimilar] (MABL-4582) | MABL-4582 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-CD19 mAbs [Denintuzumab Biosimilar] (MABL-4583) | MABL-4583 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
联系我们
Copyright © 2012-2029 西安迈博睿(Mabioway)生物科技有限公司 版权所有
地址:陕西省西安市浐灞生态区广运潭大道南段4555号长安大学科技园4号楼A单元2层
电话:15339069646 邮箱:info@mabioway.cn
